Pinnacle Financial Partners Inc Haleon PLC Transaction History

Pinnacle Financial Partners Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$8.02 - $8.67 $15,029 - $16,247	-1,874 Reduced 11.99%	13,750 $116,000
Q4 2023 Jan 22, 2024	BUY	$7.78 - $8.62 $8,736 - $9,680	1,123 Added 7.74%	15,624 $128,000
Q3 2023 Nov 03, 2023	SELL	$7.85 - $8.94 $3,414 - $3,888	-435 Reduced 2.91%	14,501 $120,000
Q2 2023 Aug 07, 2023	BUY	$8.04 - $9.0 $80 - $90	10 Added 0.07%	14,936 $125,000
Q1 2023 Apr 26, 2023	BUY	$7.57 - $8.37 $1,831 - $2,025	242 Added 1.65%	14,926 $121,000
Q4 2022 Feb 03, 2023	BUY	$5.96 - $8.06 $87,516 - $118,353	14,684 New	14,684 $117,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Financial Partners Inc with notifications on news.